Literature DB >> 18347548

The use of Dacron graft for cavo-cavostomy in orthotopic liver transplantation.

Hoonbae Jeon1, Patrick P McHugh, Ambar Banerjee, Roberto Gedaly, Thomas D Johnston, Dinesh Ranjan.   

Abstract

The end-to-end "interposition" technique and end-to-side "piggyback" technique are standard approaches to in situ anastomosis during orthotopic liver transplantation. We demonstrate that anastomosis of liver allograft to a Dacron vena cava graft can be a feasible solution if traditional anastomoses cannot be used. A 55-year-old man with end-stage liver failure from alcoholic cirrhosis underwent orthotopic liver transplantation; however, an intraoperative complication during recipient hepatectomy rendered the native vena cava unsalvageable. In addition, the donor vena cava was too short to bridge the caval defect for interposition. We therefore used Dacron for an in situ graft to span the gap, with subsequent anastomosis of the allograft to the prosthetic graft in piggyback fashion. The patient did well postoperatively; his only major complication was late anastomotic stenosis, which was treated successfully with balloon dilatation. Unfortunately the patient became recidivous and expired ten months posttransplant, despite indications of satisfactory allograft function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347548     DOI: 10.1097/TP.0b013e3181642d1e

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Life-saving super-urgent liver transplantation with replacement of retrohepatic vena cava by dacron graft.

Authors:  Paolo Aseni; Andrea Lauterio; Abdallah Omar Slim; Alessandro Giacomoni; Luca Lamperti; Luciano De Carlis
Journal:  HPB Surg       Date:  2010-07-27

Review 2.  Devascularization of the superior mesenteric vein without reconstruction during surgery for retroperitoneal liposarcoma: A case report and review of literature.

Authors:  Run-Chen Miao; Yong Wan; Xiao-Gang Zhang; Xing Zhang; Yan Deng; Chang Liu
Journal:  World J Gastroenterol       Date:  2018-06-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.